|
1
|
de Oliveira JM Ferreira, Remédios C,
Oliveira H, Pinto P, Pinho F, Pinho S, Costa M and Santos C:
Sulforaphane induces Dna damage and mitotic abnormalities in human
osteosarcoma mg-63 cells: Correlation with cell cycle arrest and
apoptosis. Nutr Cancer. 66:325–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walter I, Wolfesberger B, Miller I, Mair
G, Burger S, Gallè B and Steinborn R: Human osteosarcoma cells
respond to sorafenib chemotherapy by downregulation of the tumor
progression factors S100A4, CXCR4 and the oncogene FOS. Oncol Rep.
31:1147–1156. 2014.PubMed/NCBI
|
|
3
|
Xu H, Mei Q, Shi L, Lu J, Zhao J and Fu Q:
Tumor-Suppressing effects of miR451 in human osteosarcoma. Cell
Biochem Biophys. 69:163–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li R, Zhang W, Cui J, Shui W, Yin L, Wang
Y, Zhang H, Wang N, Wu N, Nan G, et al: Targeting BMP9-promoted
human osteosarcoma growth by inactivation of notch signaling. Curr
Cancer Drug Targets. 14:274–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of mir-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu Y, Zhu H, Lv L, Zhou Y and Huo J:
MiRNA s in oesophageal squamous cancer. Neth J Med. 71:69–75.
2013.PubMed/NCBI
|
|
7
|
Lai X, Wolkenhauer O and Vera J: Modeling
miRNA regulation in cancer signaling systems: miR-34a regulation of
the p53/Sirt1 signaling module. Methods Mol Biol. 880:87–108. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mo MH, Chen L, Fu Y, Wang W and Fu SW:
Cell-free circulating miRNA biomarkers in cancer. J Cancer.
3:432–448. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmed FE: miRNA as markers for the
diagnostic screening of colon cancer. Expert Rev Anticancer Ther.
14:463–485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu H, Mei Q, Xiong C and Zhao J:
Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell
Biochem Biophys. 69:319–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu H, Liu X and Zhao J: Down-regulation of
miR-3928 promoted osteosarcoma growth. Cell Physiol Biochem.
33:1547–1556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mei Q, Li F, Quan H, Liu Y and Xu H:
Busulfan inhibits growth of human osteosarcoma through miR-200
family microRNAs in vitro and in vivo. Cancer Sci. 105:755–762.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiyomaru T, Yamamura S, Fukuhara S,
Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I,
et al: Genistein up-regulates tumor suppressor microRNA-574-3p in
prostate cancer. PLoS One. 8:e589292013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji S, Ye G, Zhang J, Wang L, Wang T, Wang
Z, Zhang T, Wang G, Guo Z, Luo Y, et al: miR-574-5p negatively
regulates Qki6/7 to impact β-catenin/Wnt signalling and the
development of colorectal cancer. Gut. 62:716–726. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foss KM, Sima C, Ugolini D, Neri M, Allen
KE and Weiss GJ: miR-1254 and miR-574-5p: Serum-based microRNA
biomarkers for early-stage non-small cell lung cancer. J Thorac
Oncol. 6:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui J, Cheng Y, Zhang P, Sun M, Gao F, Liu
C and Cai J: down regulation of miR200c promotes radiation-induced
thymic lymphoma by targeting BMI1. J Cell Biochem. 115:1033–1042.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schutte M: DPC4/SMAD4 gene alterations in
human cancer, and their functional implications. Ann Oncol.
10:(Suppl 4). 56–59. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kowanetz M, Valcourt U, Bergström R,
Heldin CH and Moustakas A: Id2 and Id3 define the potency of cell
proliferation and differentiation responses to transforming growth
factor beta and bone morphogenetic protein. Mol Cell Biol.
24:4241–4254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J,
Yang Q, Xu Y and Li F: Aberrant expression of microRNAs in gastric
cancer and biological significance of miR-574-3p. Int
Immunopharmacol. 13:468–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meyers-Needham M, Ponnusamy S, Gencer S,
Jiang W, Thomas RJ, Senkal CE and Ogretmen B: Concerted functions
of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide
synthase 1 expression in human cancer cells. EMBO Mol Med. 4:78–92.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang
B, Min L and Liu W: miRNA-200c increases the sensitivity of breast
cancer cells to doxorubicin through the suppression of
E-cadherin-mediated PTEN/Akt signaling. Mol Med Rep. 7:1579–1584.
2013.PubMed/NCBI
|
|
25
|
Sun D, Layer R, Mueller AC, Cichewicz MA,
Negishi M, Paschal BM and Dutta A: Regulation of several
androgen-induced genes through the repression of the
miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
Oncogene. 33:1448–1457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin EC, Bratton MR, Zhu Y, Rhodes LV,
Tilghman SL, Collins-Burow BM and Burow ME: Insulin-like growth
factor-1 signaling regulates miRNA expression in MCF-7 breast
cancer cell line. PLoS One. 7:e490672012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pignot G, Cizeron-Clairac G, Vacher S,
Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B,
Amsellem-Ouazana D and Bieche I: microRNA expression profile in a
large series of bladder tumors: Identification of a 3-miRNA
signature associated with aggressiveness of muscle-invasive bladder
cancer. Int J Cancer. 132:2479–2491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ouyang L, Liu P, Yang S, Ye S, Xu W and
Liu X: A three-plasma miRNA signature serves as novel biomarkers
for osteosarcoma. Med Oncol. 30:3402013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Novello C, Pazzaglia L, Cingolani C, Conti
A, Quattrini I, Manara MC, Tognon M, Picci P and Benassi MS: miRNA
expression profile in human osteosarcoma: Role of miR-1 and
miR-133b in proliferation and cell cycle control. Int J Oncol.
42:667–675. 2013.PubMed/NCBI
|
|
30
|
Maire G, Martin JW, Yoshimoto M,
Chilton-MacNeill S, Zielenska M and Squire JA: Analysis of
miRNA-gene expression-genomic profiles reveals complex mechanisms
of microRNA deregulation in osteosarcoma. Cancer Genet.
204:138–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu
M, Feng XH, Sawaya R, Medema RH, Hung MC and Huang S: Sustained
activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer
metastasis. J Clin Invest. 124:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
